1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with valine in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (valine) | Trials (valine) | Recent Studies (post-2010) (valine) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 15,465 | 1,176 | 3,932 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boehmer, G; Heusler, P | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and valine
Article | Year |
---|---|
Platelet-activating factor contributes to the induction of long-term potentiation in the rat somatosensory cortex in vitro.
Topics: Animals; Electric Stimulation; Excitatory Amino Acid Agonists; In Vitro Techniques; Long-Term Potentiation; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Somatosensory Cortex; Valine | 2007 |